Gasparri AM - Search Results

1

Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting.

Sacchi A, Gasparri AM, Monieri M, Anderluzzi G, Colombo B, Gori A, Corti A, Curnis F. Sacchi A, et al. Among authors: gasparri am. Front Chem. 2021 May 28;9:690357. doi: 10.3389/fchem.2021.690357. eCollection 2021. Front Chem. 2021. PMID: 34124009 Free PMC article.

2

Characterisation of circulating chromogranin A in human cancer patients.

Corti A, Gasparri A, Chen FX, Pelagi M, Brandazza A, Sidoli A, Siccardi AG. Corti A, et al. Br J Cancer. 1996 Apr;73(8):924-32. doi: 10.1038/bjc.1996.183. Br J Cancer. 1996. PMID: 8611427 Free PMC article.

3

Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains.

Corti A, Longhi R, Gasparri A, Chen F, Pelagi M, Siccardi AG. Corti A, et al. Eur J Biochem. 1996 Jan 15;235(1-2):275-80. doi: 10.1111/j.1432-1033.1996.00275.x. Eur J Biochem. 1996. PMID: 8631342 Free article.

4

Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain.

Gasparri A, Sidoli A, Sanchez LP, Longhi R, Siccardi AG, Marchisio PC, Corti A. Gasparri A, et al. J Biol Chem. 1997 Aug 15;272(33):20835-43. doi: 10.1074/jbc.272.33.20835. J Biol Chem. 1997. PMID: 9252409 Free article.

5

Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) -- evidence of dimer-monomer equilibria.

Corti A, Sanchez LP, Gasparri A, Curnis F, Longhi R, Brandazza A, Siccardi AG, Sidoli A. Corti A, et al. Eur J Biochem. 1997 Sep 15;248(3):692-9. doi: 10.1111/j.1432-1033.1997.00692.x. Eur J Biochem. 1997. PMID: 9342219 Free article.

6

Tumor targeting with biotinylated tumor necrosis factor alpha: structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.

Corti A, Gasparri A, Sacchi A, Curnis F, Sangregorio R, Colombo B, Siccardi AG, Magni F. Corti A, et al. Cancer Res. 1998 Sep 1;58(17):3866-72. Cancer Res. 1998. PMID: 9731496

7

Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.

Moro M, Gasparri AM, Pagano S, Bellone M, Tornaghi P, Veglia F, Corti A, Casorati G, Dellabona P. Moro M, et al. Among authors: gasparri am. Cancer Res. 1999 Jun 1;59(11):2650-6. Cancer Res. 1999. PMID: 10363988

8

Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.

Gasparri A, Moro M, Curnis F, Sacchi A, Pagano S, Veglia F, Casorati G, Siccardi AG, Dellabona P, Corti A. Gasparri A, et al. Cancer Res. 1999 Jun 15;59(12):2917-23. Cancer Res. 1999. PMID: 10383155

9

Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells.

Ratti S, Curnis F, Longhi R, Colombo B, Gasparri A, Magni F, Manera E, Metz-Boutigue MH, Corti A. Ratti S, et al. J Biol Chem. 2000 Sep 22;275(38):29257-63. doi: 10.1074/jbc.M003796200. J Biol Chem. 2000. PMID: 10875933 Free article.

10

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A. Curnis F, et al. Nat Biotechnol. 2000 Nov;18(11):1185-90. doi: 10.1038/81183. Nat Biotechnol. 2000. PMID: 11062439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters